Skip Nav Destination
Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study
Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases
Issue Archive
Table of Contents
EXCEPTIONAL CASE REPORT
GENE THERAPY
Gene transfer into hematopoietic stem cells reduces HLH manifestations in a murine model of Munc13-4 deficiency
Tayebeh Soheili,Amandine Durand,Fernando E. Sepulveda,Julie Rivière,Chantal Lagresle-Peyrou,Hanem Sadek,Geneviève de Saint Basile,Samia Martin,Fulvio Mavilio,Marina Cavazzana,Isabelle André-Schmutz
HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY AND IMMUNOTHERAPY
LYMPHOID NEOPLASIA
Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss
Muhammad Zahoor,Marita Westhrin,Kristin Roseth Aass,Siv Helen Moen,Kristine Misund,Katarzyna Maria Psonka-Antonczyk,Mariaserena Giliberto,Glenn Buene,Anders Sundan,Anders Waage,Anne-Marit Sponaas,Therese Standal
MYELOID NEOPLASIA
Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study
Clinical Trials & Observations
Sigrun Thorsteinsdottir,Sigrun H. Lund,Ebba K. Lindqvist,Marianna Thordardottir,Gunnar Sigurdsson,Rene Costello,Debra Burton,Hlif Steingrimsdottir,Vilmundur Gudnason,Gudny Eiriksdottir,Kristin Siggeirsdottir,Tamara B. Harris,Ola Landgren,Sigurdur Y. Kristinsson
RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
TRANSFUSION MEDICINE
TRANSPLANTATION
Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases
Clinical Trials & Observations
John A. Snowden,for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE),Manuela Badoglio,for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE),Myriam Labopin,for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE),Sebastian Giebel,for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE),Eoin McGrath,for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE),Zora Marjanovic,for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE),Joachim Burman,for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE),John Moore,for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE),Montserrat Rovira,for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE),Nico M. Wulffraat,for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE),Majid Kazmi,for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE),Raffaella Greco,for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE),Emilian Snarski,for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE),Tomas Kozak,for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE),Kirill Kirgizov,for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE),Tobias Alexander,for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE),Peter Bader,for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE),Riccardo Saccardi,for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE),Dominique Farge,for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE)
-
Cover Image
Cover Image
COVER FIGURE
Newly identified hematopoietic stem cell–derived marrow endosteal cell (red cell) characterized as CD45−F4/80lo residing amongst osteoblasts in murine bone marrow. See the article by Overholt et al. - PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Advertisement intended for health care professionals